AMENDMENT AND WAIVER TO THE PATENT PURCHASE AGREEMENTPatent Purchase Agreement • November 16th, 2017 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances)
THIS AMENDMENT and WAIVER, dated as of November 14, 2017, (this “Amendment”) to the Patent Purchase Agreement referred to below is entered into by and between StemSpine, LLC, a Nevada limited liability company (“StemSpine”), a wholly owned subsidiary of Creative Medical Technologies, Inc., which is a wholly owned subsidiary of Creative Medical Technology Holdings, Inc., a Nevada corporation (“CELZ”), and Creative Medical Health, Inc., a Delaware corporation (“Seller”).
